🇺🇸 FDA
Pipeline program

[68Ga]BED003 injection

BED-FAP-201

Phase 2 small_molecule active

Quick answer

[68Ga]BED003 injection for Colorectal cancer (CRC), gastric cancer (GC), pancreatic ductal adenocarcinoma (PDAC), invasive lobular breast cancer (ILC), and epithelial ovarian cancer (EOC). is a Phase 2 program (small_molecule) at Blue Earth Diagnostics Ireland Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Blue Earth Diagnostics Ireland Ltd
Indication
Colorectal cancer (CRC), gastric cancer (GC), pancreatic ductal adenocarcinoma (PDAC), invasive lobular breast cancer (ILC), and epithelial ovarian cancer (EOC).
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials